US Spine (‘USS’) is a privately held medical technology company that designs, develops, manufactures and markets proprietary spine implants which facilitate a less invasive approach to achieving tissue and motion preservation.

Born from the incubator space at Innovation Centre only four years ago, US Spine has now grown to over 30 employees, has received FDA clearance of 6 products with another 7 on the horizon and is expected to generate revenues in excess of $16 Million in the following year.

“Due to the flexibility of our facilities and work spaces, Innovation Centre was able to accommodate US Spine as they have grown into the company they are today” says HDG’s asset manager, Marc Turner. “We congratulate US Spine on their success”.